CD
CareDx, Inc
CDNA · NASDAQ
$64.60 +3.69% (+$2.30)
1M +28.92%
Market Cap $3.34B
P/E Ratio 30.11x
Div. Yield -
ROE 32.81%
Bulios Fair Price
$57.93
10.3% downside
Current Price
$64.6
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CDNA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
7/9Valuation
15 /100
Expensive EV/EBITDA 192.03x
P/S 7.30x
P/B 7.85x
Growth
37 /100
Stable Book val. growth 11.07%
Rev. growth 5.68%
FCF growth N/A
Profitability
70 /100
Strong Net margin 24.23%
Op. margin 0.92%
FCF margin 18.57%
Quality
56 /100
Average ROE 32.81%
ROA 20.83%
Asset turnover 0.86x
Debt
100 /100
Low Current ratio 4.58x
Net debt/EBITDA -22.78x
Debt/Equity 0.05x
Stability
20 /100
Unstable Rev. volatility 17.13%
EPS volatility 156.29%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CDNA
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
John Walter Hanna Jr.
Employees
763
Headquarters
Brisbane
Upcoming events
03 NOV
Earnings
Upcoming earnings report